Medical Weight Loss
GLP-1 Weight Loss & Metabolic Medicine in Dallas, TX
Compounded semaglutide and tirzepatide programs, plus brand-name Wegovy through NovoCare Pharmacy (from $349/month) and Zepbound through LillyDirect (from $299/month) for eligible patients. Cash pay and insurance pathways available. Personalized dosing, ongoing provider oversight, and real clinical support. This is medical weight management, not a quick-fix program.
How It Works
Medical Weight Management Built Around Your Biology
Weight loss is influenced by more than calories. Hormones, insulin resistance, thyroid function, stress physiology, and metabolic adaptation all play a role. Our programs address the full picture, not just the number on the scale.
We offer compounded semaglutide and tirzepatide as well as brand-name Wegovy through NovoCare Pharmacy and Zepbound through LillyDirect for eligible patients. Cash pay self-pay pricing starts at $349/month for Wegovy and $299/month for Zepbound — significantly less than retail pharmacy pricing. Insurance pathways are also available. Your provider will help determine the right medication and pathway based on your history, goals, and budget.
Important notice about compounded medications: Compounded semaglutide and tirzepatide are not FDA-approved and are not the same as brand-name Wegovy, Ozempic, Mounjaro, or Zepbound. They are prepared by a licensed 503A compounding pharmacy and have not undergone FDA review. Individual results vary. All prescribing is done after a thorough medical evaluation by your Navara provider.
Fill out a brief medical intake before your appointment. We review your health history, prior weight loss experience, and current medications before your consult.
Meet with Jessica Boggs, APRN or to review your goals, history, and ideal medication pathway. Labs can be added for $150 flat or billed to insurance through Quest if needed.
If you qualify, your prescription is sent to our partner compounding pharmacy and medication ships directly to your door with all supplies included.
Continued provider access for titration, side effect management, refills, and protocol adjustments. This is not set-and-forget prescribing.
Step 1 Get Started
Book Your New Patient Consultation
- Full review of health history, goals, and prior weight loss experience
- Personalized medication pathway recommendation (semaglutide vs. tirzepatide)
- Labs can be added for $150 flat or billed to insurance through Quest
- Prescription sent to compounding pharmacy if you qualify
- Ongoing provider access for adjustments and refills
- $50 of your consult fee applied to your first order if you start within 7 days
Not sure yet? A 15-minute quick consult is available for $50 and applies toward your full consultation if you decide to move forward.
Program Pricing
Transparent Pricing. No Hidden Fees.
All medication pricing is per month and based on dosage tier. Your provider will recommend the appropriate starting tier based on your health history and goals. Financing available through Cherry.
Programs are available in-clinic in Dallas, TX and via telehealth across Texas. Medication ships directly from our partner compounding pharmacy all supplies included.
Brand-name Wegovy and Zepbound are available for eligible patients with insurance coverage. Your provider will help determine the best pathway for you.
Wegovy and Zepbound self-pay pricing through NovoCare and LillyDirect requires that refills be completed within 45 days of your previous supply to maintain the lowest available price tier. To protect your pricing, Navara Health requires all brand-name refill requests to be submitted at least 7 business days before day 38 of your current supply.
This gives our team time to review and send your prescription electronically to the pharmacy, and gives the pharmacy time to process and ship before your 45-day window closes. Refill requests received after this window may result in a gap in supply or loss of self-pay pricing eligibility. Navara Health is not responsible for pricing changes or supply gaps resulting from late refill requests.
Save More
Weight Loss Accelerator Package
Skip the per-item sticker shock. This package bundles everything you need to start strong consult, labs, your first month of medication, metabolic injection support, and a follow-up built right in.
- Weight loss consultation ($125 value)
- Lab panel ($150 value)
- First month compounded semaglutide (Tier 1)
- 2 in-office metabolic injections (B12 or Lipo-Mino)
- Follow-up visit included
Save versus booking individually. Ideal for patients ready to start immediately.
Book This Package- Weight loss consultation ($125 value)
- Lab panel ($150 value)
- First month compounded tirzepatide (Tier 1)
- 2 in-office metabolic injections (B12 or Lipo-Mino)
- Follow-up visit included
Our highest-performing GLP-1 pathway. Dual GIP/GLP-1 mechanism for greater weight loss results.
Book This PackageMedical Eligibility
Not Everyone Qualifies. That Is How It Should Be.
Semaglutide and tirzepatide are prescription medications. A thorough medical evaluation is required before any prescription is written. The following conditions may disqualify you or require additional review at your consultation.
GLP-1 medications are not indicated for individuals with a BMI below 27. A BMI of 27 or higher with at least one weight-related health condition is typically required for prescribing.
A personal history of anorexia, bulimia, binge eating disorder, or other clinically diagnosed eating disorders is a contraindication that requires careful provider evaluation.
Compounded semaglutide and tirzepatide are not appropriate for patients with Type 1 diabetes or those using insulin. Patients with Type 2 diabetes require additional review.
Active gallbladder disease or a history of gallstones may affect eligibility. GLP-1 medications have been associated with gallbladder-related events and require provider evaluation.
Active substance abuse or a recent history of substance use disorder is reviewed on a case-by-case basis. This must be disclosed at your consultation.
Patients who have undergone bariatric surgery within the past 12 months require additional evaluation before GLP-1 medications can be considered.
A personal history of pancreatitis is a contraindication. GLP-1 receptor agonists have been associated with pancreatitis risk and cannot be prescribed to patients with this history.
A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Type 2 (MEN2) is an absolute contraindication for GLP-1 medications.
GLP-1 medications are not appropriate during pregnancy or breastfeeding. Patients who are actively planning to become pregnant in the near term are also not appropriate candidates.
Patients with a history of diabetic retinopathy require additional evaluation. Rapid glycemic changes associated with GLP-1 therapy may affect retinopathy status and must be reviewed.
This list is not exhaustive. Your provider will review your full medical history, current medications, and any additional risk factors at your consultation before any prescription is written. Disclosing your complete health history is essential for your safety. If you are unsure whether a condition applies to you, bring it up at your appointment. We will not prescribe without a thorough evaluation.
BMI Check
Check Your BMI Before You Book.
A BMI of 27 or higher is one of the baseline eligibility criteria for GLP-1 medications at Navara Health. Use this calculator to get a quick read on where you stand before your consultation.
BMI is one factor, not the whole picture. Your provider will also review your health history, current medications, and any weight-related conditions at your consultation. Some patients with a BMI slightly below 27 may still qualify depending on clinical context.
BMI 30+ — typically eligible
BMI 27-29.9 — eligible with at least one weight-related condition (high blood pressure, pre-diabetes, sleep apnea, etc.)
BMI under 27 — generally not eligible
This result is for informational purposes only and does not constitute medical advice. BMI is one of several factors reviewed at your consultation. It does not guarantee eligibility or ineligibility for GLP-1 medications. Only your Navara provider can determine clinical appropriateness after a full medical evaluation.
Common Questions
What Patients Ask Most
Ready to Start?
Book Your Weight Loss Consultation Today.
$125 new patient consultation with Jessica Boggs, APRN or Telehealth available across Texas. $50 applies toward your first medication order if you start within 7 days.
Financing available through Cherry · Apply in minutes · No hard credit pull to check your rate